Description
Structural model of TRPV1 channel pore domain and phytocannabinoid binding sites. Cannabidiol and other phytocannabinoids may exert antiepileptic effects through TRPV1 activation followed by desensitization.
Figure 87
DiagramSource Paper
Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.Cite This Figure
![Figure 87: Structural model of TRPV1 channel pore domain and phytocannabinoid binding sites. Cannabidiol and other phytocannabinoids may exert antiepileptic effects through TRPV1 activation followed by desensitization.]() > Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)
<figure> <img src="" alt="Structural model of TRPV1 channel pore domain and phytocannabinoid binding sites. Cannabidiol and other phytocannabinoids may exert antiepileptic effects through TRPV1 activation followed by desensitization." /> <figcaption>Figure 87. Structural model of TRPV1 channel pore domain and phytocannabinoid binding sites. Cannabidiol and other phytocannabinoids may exert antiepileptic effects through TRPV1 activation followed by desensitization.<br> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption> </figure>